• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

CellaVision

126.20 SEK

-1.71 %

1,477 following

CEVI

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-1.71 %
+6.59 %
-17.30 %
-19.72 %
-17.08 %
-34.95 %
-39.03 %
-63.23 %
+708.97 %

CellaVision operates in the medical technology industry and focuses on the development and manufacture of systems for digital blood analysis. The company focuses on digital cell morphology and offers innovations for analyzers, instruments, reagents and software used in hematology laboratories. The company's products are aimed at healthcare institutions and laboratories worldwide. CellaVision was founded in 1994 and is headquartered in Lund, Sweden.

Read more
Market cap
3.01B SEK
Turnover
7.64M SEK
Revenue
758.97M
EBIT %
26.62 %
P/E
19.66
Dividend yield-%
2.18 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
17/7
2026

Interim report Q2'26

29/10
2026

Interim report Q3'26

4/2
2027

Annual report '26

Regulatory press release6/5/2026, 5:00 PM

Styrelsen utser Steve Ferguson till ny verkställande direktör för CellaVision AB (publ)

CellaVision
Regulatory press release6/5/2026, 5:00 PM

The Board of CellaVision AB appoints Steve Ferguson as CEO

CellaVision
Regulatory press release4/28/2026, 2:45 PM

Kommuniké från årsstämma i CellaVision AB (publ)

CellaVision

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/28/2026, 2:45 PM

Bulletin from the Annual General Meeting of CellaVision AB (publ)

CellaVision
CellaVision, Audiocast, Q1'26
Webcast4/24/2026, 9:00 AM

CellaVision, Audiocast, Q1'26

CellaVision
Regulatory press release4/24/2026, 5:20 AM

Svagare kvartal till följd av lägre försäljning i EMEA

CellaVision
Regulatory press release4/24/2026, 5:20 AM

Softer quarter due to lower sales in EMEA

CellaVision
Press release4/21/2026, 12:00 PM

Modular Finance IR Consensus: CellaVision – Consensus estimates Q1 2026

CellaVision
Regulatory press release4/16/2026, 9:20 AM

Valberedningens förslag inför årsstämman 2026 i CellaVision AB

CellaVision
Regulatory press release4/16/2026, 9:20 AM

The Nomination Committee’s proposals for the 2026 Annual General Meeting of CellaVision AB

CellaVision
Third party research4/13/2026, 11:35 AM

Cellavision: Dags att växla upp - InvesteraMera

CellaVision digitaliserar blodanalys och frigör viktig tid för sjukvården. Efter en period av inbromsad tillväxt och tuffare konkurrens växlar bolaget nu upp. Genom ökade FoU-investeringar och nya produktlanseringar siktar CellaVision på att försvara...

CellaVision
Press release4/10/2026, 6:20 AM

Inbjudan till presentation av CellaVisions rapport för första kvartalet 2026, den 24 april kl. 11:00

CellaVision
Press release4/10/2026, 6:20 AM

Invitation to Presentation of the CellaVision Report for the First Quarter 2026 on April 24, at 11:00 CEST

CellaVision
Regulatory press release4/1/2026, 6:20 AM

CellaVision publicerar års- och hållbarhetsredovisning för 2025

CellaVision
Regulatory press release4/1/2026, 6:20 AM

CellaVision publishes its 2025 Annual and Sustainability Report

CellaVision
Regulatory press release3/25/2026, 7:00 AM

KALLELSE TILL ÅRSSTÄMMA I CELLAVISION AB (PUBL)

CellaVision
Regulatory press release3/25/2026, 7:00 AM

NOTICE OF ANNUAL GENERAL MEETING IN CELLAVISION AB (publ)

CellaVision
Press release3/11/2026, 7:20 AM

CellaVision® Bone Marrow Aspirate Application lanseras i EMEA

CellaVision
Press release3/11/2026, 7:20 AM

The new CellaVision® Bone Marrow Aspirate Application launches in EMEA

CellaVision
Regulatory press release2/11/2026, 1:23 PM

Finansinspektionen: Flaggningsmeddelande i CellaVision AB

CellaVision